CRMD Stock Price History and Quote Analysis Insights for Investors
CorMedix Inc.
Stock Price Today
CorMedix Inc. (CRMD) stock declined over -4.45%, trading at $8.38 on NASDAQ, down from the previous close of $8.77. The stock opened at $8.75, fluctuating between $8.35 and $8.89 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Company Information
| Employees | 82 |
| Beta | 1.58 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
CorMedix Inc. (NASDAQ: CRMD) stock price is $8.38 in the last trading session. During the trading session, CRMD stock reached the peak price of $8.89 while $8.35 was the lowest point it dropped to. The percentage change in CRMD stock occurred in the recent session was -4.45% while the dollar amount for the price change in CRMD stock was -$0.39.
The NASDAQ listed CRMD is part of Biotechnology industry that operates in the broader Healthcare sector. CorMedix Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Matthew T. David M.D.
Executive Vice President & Chief Financial Officer
Dr. Phoebe Mounts Esq., Ph.D.
EVice President, Gen. Counsel, Head of Regulatory, Compliance & Legal and Sec.
Donna Ucci
Senior Vice President & Head of Global Quality
Ms. Elizabeth Masson-Hurlburt B.A.
Executive Vice President and Head of Clinical & Medical Affairs
Ms. Erin Mistry
Executive Vice President & Chief Commercial Officer
Ms. Erin Miststry
Executive Vice President & Chief Commercial Officer
Dr. Tushar Mukherjee
Senior Vice President & Head of Technical Operations
Mr. Joseph Todisco MBA
Chief Executive Officer & Director
Ms. Elizabeth Hurlburt
Executive Vice President and Head of Clinical & Medical Affairs
CRMD's closing price is 189.97% higher than its 52-week low of $2.89 where as its distance from 52-week high of $13.85 is -39.49%.
Number of CRMD employees currently stands at 82.
Official Website of CRMD is: https://www.cormedix.com
CRMD could be contacted at phone 908 517 9500 and can also be accessed through its website. CRMD operates from 300 Connell Drive, Berkeley Heights, NJ 07922, United States.
CRMD stock volume for the day was 853.76K shares. The average number of CRMD shares traded daily for last 3 months was 1.17M.
The market value of CRMD currently stands at $508.47M with its latest stock price at $8.38 and 60.68M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com